SCHEMBL18993496

SCHEMBL18993496

CCC(C)(C)P(=O)(OCC(C)(C)C)N1CCC(N2CCCCC2)CC1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL408337 0.88 HRH3 (0.34) MAPK1MEN1KMT2AHRH3
SCHEMBL408977 0.86 HRH3 (0.32) MAPK1MEN1KMT2AHRH3
SCHEMBL21316725 0.83 MAPK1 (0.30) MAPK1
SCHEMBL22389189 0.80 MAPK1 (0.32) MAPK1MEN1KMT2AHRH3
SCHEMBL26269608 0.77 HRH3 (0.33) MAPK1MEN1KMT2AHRH3
SCHEMBL23347753 0.77 HRH3 (0.32) MEN1KMT2AHRH3
SCHEMBL21172179 0.76
SCHEMBL21172177 0.76 MAPK1 (0.31) MAPK1
SCHEMBL18993481 0.75 MAPK1 (0.32) MAPK1
SCHEMBL18993493 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682097-B2 Oligonucleotide analogues targeting human LMNA SAREPTA THERAPEUTICS, INC. (US) 2017-06-20 US disclosed